Becton Dickinson and Company (BDX) : Thursdays money flow data in Becton Dickinson and Company (BDX) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $13.06 million, whereas, $9.62 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.36, in favor of the bulls. The total money flow into the stock was $3.44 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $2.51 million. The total value of block trades done on upticks was $2.51 million. Becton Dickinson and Company (BDX) fell $0.03 and traded at $175.91, down -0.02% for the day, over previous days close. On a weekly basis, the shares are 0.15% over the previous weeks close.
The stock has recorded a 20-day Moving Average of 3.8% and the 50-Day Moving Average is 5.22%. Shares have rallied 19.78% from its 1 Year high price. On Jul 11, 2016, the shares registered one year high at $177.01 and the one year low was seen on Sep 28, 2015. The 50-Day Moving Average price is $168.77 and the 200 Day Moving Average price is recorded at $155.70.
Becton Dickinson and Company (NYSE:BDX): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $177.10 and $175.78 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $177.41. The buying momentum continued till the end and the stock did not give up its gains. It closed at $176.53, notching a gain of 0.34% for the day. The total traded volume was 668,450 . The stock had closed at $175.94 on the previous day.
In an insider trading activity, Gallagher John E, officer (VP, Corp Finance and Treasurer) of Becton Dickinson & Co, unloaded 1,931 shares at an average price of $169.87 on June 13, 2016. The total amount of the transaction was worth $328,019, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.